Skip to main content
SpringerLink
Log in

Gout and the risk of Parkinson’s disease in Denmark

  • Letter to the Editor
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010;345(1–2):91–104.

    Article  PubMed  CAS  Google Scholar 

  2. Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol 2013. doi:10.1007/s10654-012-9760-0.

  3. Church WH, Ward VL. Uric acid is reduced in the substantia nigra in Parkinson’s disease: effect on dopamine oxidation. Brain Res Bull. 1994;33(4):419–25.

    Article  PubMed  CAS  Google Scholar 

  4. Tohgi H, Abe T, Takahashi S, Kikuchi T. The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1993;6(2):119–26.

    Article  PubMed  CAS  Google Scholar 

  5. Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM. Observations on serum uric acid levels and the risk of idiopathic Parkinson’s disease. Am J Epidemiol. 1996;144(5):480–4.

    Article  PubMed  CAS  Google Scholar 

  6. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58(5):797–800.

    Article  PubMed  Google Scholar 

  7. Weisskopf MG, O’Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson’s disease. Am J Epidemiol. 2007;166(5):561–7.

    Article  PubMed  CAS  Google Scholar 

  8. Larumbe Ilundain R, Ferrer Valls JV, Vines Rueda JJ, Guerrero D, Fraile P. Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson’s disease. Rev Esp Salud Publica. 2001;75(1):43–53.

    Article  PubMed  CAS  Google Scholar 

  9. Annanmaki T, Muuronen A, Murros K. Low plasma uric acid level in Parkinson’s disease. Mov Disord. 2007;22(8):1133–7.

    Article  PubMed  Google Scholar 

  10. Cipriani S, Chen X, Schwarzschild MA. Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosis. Biomark Med. 2010;4(5):701–12.

    Article  PubMed  CAS  Google Scholar 

  11. Alonso A, Rodriguez LA, Logroscino G, Hernan MA. Gout and risk of Parkinson disease: a prospective study. Neurology. 2007;69(17):1696–700.

    Article  PubMed  Google Scholar 

  12. De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. Gout and the risk of Parkinson’s disease: a cohort study. Arthritis Rheum. 2008;59(11):1549–54.

    Article  PubMed  Google Scholar 

  13. Lynge E, Sandegaard JL, Rebolj M. The danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–3.

    Article  PubMed  Google Scholar 

  14. Pedersen CB. The danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–5.

    Article  PubMed  Google Scholar 

  15. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care. 2011;34(5):1102–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the National Institutes of Environmental Health Sciences, USA (Grant No. R01 ES013717). Partial funding was also provided by the National Institutes of Neurologic Diseases and Stroke, USA for the UCLA Udall Parkinson Disease Center of Excellence Grant No. P50 NS038367). The funding source had no role in the design or analysis of the study or in the decision to submit the manuscript for publication.

Author information

Authors and Affiliations

  1. Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA

    Eva Schernhammer

  2. Department of Epidemiology, Harvard School of Public Health, Boston, MA, 02115, USA

    Eva Schernhammer

  3. LBI-ACR and ACR-ITR VIEnna/CEADDP, Vienna, Austria

    Eva Schernhammer

  4. Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, 90095, USA

    Jiaheng Qiu & Beate Ritz

  5. Department of Neurology, Odense University Hospital, Odense, Denmark

    Lene Wermuth

  6. Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

    Christina Funch Lassen & Soren Friis

  7. Channing Division of Network Medicine, 181 Longwood Avenue, Boston, MA, 02115, USA

    Eva Schernhammer

Authors
  1. Eva Schernhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiaheng Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lene Wermuth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christina Funch Lassen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Soren Friis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Beate Ritz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eva Schernhammer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schernhammer, E., Qiu, J., Wermuth, L. et al. Gout and the risk of Parkinson’s disease in Denmark. Eur J Epidemiol 28, 359–360 (2013). https://doi.org/10.1007/s10654-013-9791-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-013-9791-1

Keywords

Search

Navigation